Visiongate 3D > Investors

Investors

VisionGate, Inc. was incorporated in 2001 with a focus in developing a new quality in cellular imaging, specifically targeted at automated cancer diagnostics. The team and leadership have considerable prior-company experience in the creation of cutting-edge technology and its stewardship through product development and manufacturing to market introduction, including FDA 510(k) and Class III PMA processes, foreign regulatory approvals, and the reimbursement process as required in the in vitro diagnostics (IVD) marketplace.

Contact Us

If you are interested in learning more about the VisionGate Cell-CT technology and would like to speak with someone, please complete the short inquiry form and a VisionGate representative will contact you as soon as possible.

This website may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and made in reliance on the "safe harbor" provisions of said act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of VisionGate management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, the acceptance by customers of our products, our ability to develop new products cost-effectively, our ability to raise capital in the future, the development by competitors of products using improved or alternative technology, the retention of key employees and general economic conditions. Forward-looking statements are subject to change without notice.

Contact Us

If you are interested in learning more about the VisionGate Cell-CT™ technology and would like to speak with someone, please complete this short inquiry form and a VisionGate representative will contact you as soon as possible.